Tag: biotech
-
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025
Vertex to Present at UBS Global Healthcare Conference on November 11, 2025 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its leadership will participate in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 11, 2025, at 10:15 a.m. ET. The discussion will…
-
LassoESM: A New AI-Driven Path to Therapeutic Lasso Peptides
Revealing a new AI tool for lasso peptides In the race to develop novel therapeutics for cancer and infectious diseases, lasso peptides have emerged as a promising class. Their knot-like structures confer remarkable stability and diverse biological activities, making them attractive candidates for future drugs. A collaboration led by the Carl R. Woese Institute for…
-
MIT Engineers Unstick Cells on Demand With Bubble-Driven Detachment in Bioreactors
Revolutionizing cell adhesion in bioreactors and beyond MIT researchers have unveiled a scalable, high-throughput method to detach cells from surfaces on demand using electrochemically generated bubbles. Published in Science Advances, the approach could dramatically reduce downtime and waste across industries that rely on cell cultures, including algae bioreactors for carbon capture, pharmaceutical manufacturing, biofuels, biosensors,…
-
MIT Engineers Solve Sticky-cell Problem In Bioreactors And Other Industries
Introduction: A Simple Problem, Big Impact Bioreactors and related processes across industries—from algae farming in climate-friendly carbon capture efforts to manufacturing biologic drugs—face a stubborn obstacle: cells sticking to surfaces. This adhesion reduces light exposure in photobioreactors, clogs harvesting lines, and forces costly downtime for cleaning and sanitation. MIT researchers have now introduced a high-throughput,…
-
ASX Advances as Banks, Miners Lead Gains Despite Global Jitters
Australian Shares Rise as Banks and Miners Drive the Rally The Australian share market climbed on Wednesday, with the S&P/ASX 200 up 91.5 points (about 1%) to close at 8,990.90. The session followed a modest 0.2% gain on Tuesday, when mining stocks helped lift sentiment. Investors navigated a mix of domestic policy talk and international…
-
CancerVax Precision Therapy Demonstrates Liver-Sparing Potential in In-Vitro Tests
Breakthrough in Precision Cancer Therapy: Liver-Sparing in Early Studies Lehi, Utah — CancerVax, Inc., a pre-clinical biotechnology company, announced today that recent in-vitro studies demonstrate a significant reduction in liver toxicity for its universal cancer treatment platform. The findings address a long-standing challenge in oncology: protecting healthy liver tissue while delivering effective cancer-killing therapy. If…
-
MS Remyelination: New Drug Candidates Show Promise
Overview: A hopeful step toward remyelination in MS Multiple sclerosis (MS) is a chronic autoimmune disease that disrupts nerve signals when the immune system damages the myelin sheath, the protective insulation around nerve fibers. More than 2.9 million people worldwide live with MS, and symptoms can range from numbness and vision loss to paralysis. While…
-
Scientists unveil first blood test to diagnose chronic fatigue syndrome with 96% accuracy
Groundbreaking Blood Test for ME/CFS Arrives A new blood test claims to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), with an impressive overall accuracy of 96%. Developed by researchers at the University of East Anglia, the test analyzes how DNA is folded in blood samples to detect unique epigenetic patterns associated…
-
Oncology, Immunology, and Diabetes: China’s Spectacular Breakthrough in Therapeutic Innovation
China’s Rising Role in Therapeutic Innovation In recent years, China has transformed from a manufacturing powerhouse into a global hub of therapeutic innovation. Across oncology, immunology, and diabetes care, researchers and biotechs are delivering new approaches that challenge conventional treatment paradigms. The shift is driven by a mix of heavy investment, ambitious talent pipelines, and…
-
Oncology, Immunology, and Diabetes: China’s Spectacular Leap in Therapeutic Innovation
China’s Rise as a Global Leader in Therapeutic Innovation In recent years, China has transformed from a manufacturing hub into a powerhouse of therapeutic innovation. Across oncology, immunology, and metabolic diseases like diabetes, researchers and companies are pushing the boundaries of how we diagnose, treat, and manage chronic conditions. This shift is not the result…